The U.S. Chamber of Commerce’s Global Intellectual Property Center interviewed biotechnology company CEOs and Senior Executives from around the world at the 2011 BIO International Convention about the importance of their patents to their business. Here is what they said.
Maurice Wagner - Debiopharm Group
Matias Vial Valdes - Cells for Cells
Leading in Chile in Stem Cell Development
Gabor Heltovics - NanGenex Inc.
Transforming Undruggable Medicinal Compounds
Francois Curtin - GeNeuro SA
Treating MS Through Innovation
Steve Fabijanski – Agrisoma
Reducing Dependency on Petroleum
Pierre-Henri Benhamou, DBV Technologies
Revolutionizing Treatments for Peanut Allergies